<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02381717</url>
  </required_header>
  <id_info>
    <org_study_id>2014P000304</org_study_id>
    <nct_id>NCT02381717</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Femoral Nerve Block</brief_title>
  <official_title>Comparison of Ultrasound Guided Femoral Nerve Blockade and Standard Parenteral Opioid Pain Management Alone in Patients With Hip Fracture in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the study is to evaluate whether pain control achieved by Ultrasound Guided
      Femoral Nerve Blockade (USFNB) is equal in efficacy to standard pain management practice of
      parenteral injection of opioid pain medication in patients presenting to the emergency
      department (ED) with hip fracture.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this proposed protocol the investigators will conduct a prospective, randomized control
      trial comparing the efficacy of Ultrasound Guided Femoral Nerve Blockade (USFNB) versus the
      standard of care pain management by parenteral injection of opioid pain medication of
      patients presenting with hip fracture at the BIDMC ED. We hypothesize that USNFB approach
      will be non-inferior in achieving pain control (efficacy) and superior in the total dose of
      opioids (lower amount) as compared to the standard protocol. The enrolled population will be
      randomized 1:1 using a simple balanced randomization scheme.

      Participants will be surveyed six times 6 times on a Visual Analog Scale (VAS)* on their pain
      intensity reduction over 4 hours.

      Physicians performing the block will be surveyed promptly following the procedure regarding
      difficulty performing the block and its efficacy.

      Specific Aim #1: The investigators hypothesize that in patients presenting to the ED with hip
      fracture, USFNB will demonstrate equal efficacy in pain relief with fewer side effects when
      compared to conventional parenteral opioid therapy. The investigators evaluate this
      hypothesis by monitoring Visual Analogue Scales (VAS) in patients receiving either USGFNB or
      opioid therapy over the first 4 hours of observation. The side effects will be noted during
      the same interval of time.

      Specific Aim #2: The investigators hypothesize that in patients presenting to the ED with hip
      fracture, USFNB will reduce the amount of narcotic used to control pain. The investigators
      will evaluate this by studying narcotic use over the first 4 hours of evaluation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain intensity reduction</measure>
    <time_frame>4 hours after initiation of study proceduure</time_frame>
    <description>Evaluation of pain severity and relief will be assessed utilizing a Visual Analog Scale (VAS)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hip Fracture</condition>
  <arm_group>
    <arm_group_label>ultra-sound guided femoral nerve block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will receive a bed-side ultrasound guided femoral nerve block with analgesia 0.5% bupivacaine (2mg/kg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard of care- IV morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will have the femoral nerve block block with no ultrasound for guidance with analgesia (IV morphine)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ultra-sound guide</intervention_name>
    <description>Patients randomized to this arm will have the femoral nerve block with the guidance of a bedside ultrasound</description>
    <arm_group_label>ultra-sound guided femoral nerve block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine</intervention_name>
    <arm_group_label>ultra-sound guided femoral nerve block</arm_group_label>
    <other_name>femoral nerve block femoral nerve block with analgesia 0.5% bupivacaine (2mg/kg)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>morphine</intervention_name>
    <arm_group_label>standard of care- IV morphine</arm_group_label>
    <other_name>femoral nerve block block with no ultrasound for guidance with analgesia (IV morphine)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 18 years of age presenting to the ED with radiographically established
             intra-, extracapsular hip fracture, able to consent and participate in the study and
             who have moderate to severe pain (numerical pain score &gt;= 31) at the time of
             enrollment.

        Exclusion Criteria:

          -  Patients with a previous history of hypersensitivity to local anesthetics,

          -  Patients who have signs of a local infection at the site of planned needle placement.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>101 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beatrice Hoffmann, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Beatrice Hoffmann, MD PhD</last_name>
    <phone>617-754-2323</phone>
    <email>bhoffma2@bidmc.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elinita Rosseto</last_name>
    <phone>617-754-2332</phone>
    <email>erosseto@bidmc.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beatrice Hoffmann, MD PhD</last_name>
      <phone>617-754-2323</phone>
      <email>bhoffma2@bidmc.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Nathan Shapiro, MD</last_name>
      <phone>617-754-2343</phone>
      <email>nshapiro@bidmc.harvard.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Hospital</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sigel Pamela, RN</last_name>
      <phone>508-363-5286</phone>
      <email>psigel@bidmc.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Hardin John, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Morrison RS, Magaziner J, Gilbert M, Koval KJ, McLaughlin MA, Orosz G, Strauss E, Siu AL. Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci. 2003 Jan;58(1):76-81.</citation>
    <PMID>12560416</PMID>
  </reference>
  <reference>
    <citation>Christos SC, Chiampas G, Offman R, Rifenburg R. Ultrasound-guided three-in-one nerve block for femur fractures. West J Emerg Med. 2010 Sep;11(4):310-3.</citation>
    <PMID>21079698</PMID>
  </reference>
  <reference>
    <citation>Baker BC, Buckenmaier C, Narine N, Compeggie ME, Brand GJ, Mongan PD. Battlefield anesthesia: advances in patient care and pain management. Anesthesiol Clin. 2007 Mar;25(1):131-45, x. Review.</citation>
    <PMID>17400161</PMID>
  </reference>
  <reference>
    <citation>Fletcher AK, Rigby AS, Heyes FL. Three-in-one femoral nerve block as analgesia for fractured neck of femur in the emergency department: a randomized, controlled trial. Ann Emerg Med. 2003 Feb;41(2):227-33.</citation>
    <PMID>12548273</PMID>
  </reference>
  <reference>
    <citation>Malchow RJ, Black IH. The evolution of pain management in the critically ill trauma patient: Emerging concepts from the global war on terrorism. Crit Care Med. 2008 Jul;36(7 Suppl):S346-57. doi: 10.1097/CCM.0b013e31817e2fc9. Review.</citation>
    <PMID>18594262</PMID>
  </reference>
  <reference>
    <citation>Grabinsky A, Sharar SR. Regional anesthesia for acute traumatic injuries in the emergency room. Expert Rev Neurother. 2009 Nov;9(11):1677-90. doi: 10.1586/ern.09.110. Review.</citation>
    <PMID>19903026</PMID>
  </reference>
  <reference>
    <citation>O'Donnell BD, Mannion S. Ultrasound-guided femoral nerve block, the safest way to proceed? Reg Anesth Pain Med. 2006 Jul-Aug;31(4):387-8.</citation>
    <PMID>16857561</PMID>
  </reference>
  <reference>
    <citation>Marhofer P, Schrögendorfer K, Koinig H, Kapral S, Weinstabl C, Mayer N. Ultrasonographic guidance improves sensory block and onset time of three-in-one blocks. Anesth Analg. 1997 Oct;85(4):854-7.</citation>
    <PMID>9322469</PMID>
  </reference>
  <reference>
    <citation>Todd KH. Clinical versus statistical significance in the assessment of pain relief. Ann Emerg Med. 1996 Apr;27(4):439-41. Review.</citation>
    <PMID>8604855</PMID>
  </reference>
  <reference>
    <citation>Kelly AM. The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J. 2001 May;18(3):205-7.</citation>
    <PMID>11354213</PMID>
  </reference>
  <reference>
    <citation>Platts-Mills TF, Esserman DA, Brown DL, Bortsov AV, Sloane PD, McLean SA. Older US emergency department patients are less likely to receive pain medication than younger patients: results from a national survey. Ann Emerg Med. 2012 Aug;60(2):199-206. doi: 10.1016/j.annemergmed.2011.09.014. Epub 2011 Oct 26.</citation>
    <PMID>22032803</PMID>
  </reference>
  <reference>
    <citation>Bijur PE, Kenny MK, Gallagher EJ. Intravenous morphine at 0.1 mg/kg is not effective for controlling severe acute pain in the majority of patients. Ann Emerg Med. 2005 Oct;46(4):362-7.</citation>
    <PMID>16187470</PMID>
  </reference>
  <reference>
    <citation>Fredrickson MJ, Kilfoyle DH. Neurological complication analysis of 1000 ultrasound guided peripheral nerve blocks for elective orthopaedic surgery: a prospective study. Anaesthesia. 2009 Aug;64(8):836-44. doi: 10.1111/j.1365-2044.2009.05938.x.</citation>
    <PMID>19604186</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2015</study_first_submitted>
  <study_first_submitted_qc>March 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2015</study_first_posted>
  <last_update_submitted>September 25, 2017</last_update_submitted>
  <last_update_submitted_qc>September 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beth Israel Deaconess Medical Center</investigator_affiliation>
    <investigator_full_name>Beatrice Hoffmann</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>ultrasound</keyword>
  <keyword>bupivacaine</keyword>
  <keyword>femoral nerve block</keyword>
  <keyword>pain reduction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

